Use of potentially inappropriate medication in older patients with lung cancer at the end of life

Laurien Ham,Eric C T Geijteman,Mieke J Aarts,Josephina G Kuiper,Peter W A Kunst,Natasja J H Raijmakers,Loes E Visser,Lia van Zuylen,Edwin J Brokaar,Heidi P Fransen

Journal of Geriatric Oncology（2022）

引用 6|浏览9

暂无评分

摘要

Almost half of the older patients with lung cancer in the Netherlands received PIMs in their last month of life. Since PIM use is associated with reduced quality of life, it is important that health care professionals continue to critically assess which medication can be discontinued at the end of life.

查看译文

关键词

Lung cancer - older adults,Palliative care,Potentially inappropriate medications,End of life

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要